LA CaTS Supplement NOT-OD-21-101
LA CaTS Supplement NOT-OD-21-101
批准号:
10403313
负责人:
JOHN P. KIRWAN
金额:
$30.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-15 至 2023-06-30
关键词:
16 year old2019-nCoVAchievementAddressAdministrative SupplementAdultAfrican AmericanAwardBiomedical ResearchCOVID-19COVID-19 pandemicCOVID-19 testingCOVID-19 vaccinationCOVID-19 vaccineCenter for Translational Science ActivitiesChronicChurchCitiesClinicClinical SciencesCommunitiesConsultationsControl GroupsCounselingDevelopmentDiabetes MellitusDoseEnvironmentEpidemicEventFamilyFocus GroupsFoundationsFundingGoalsHealthHealth StatusHypertensionInfrastructureInstitutional Review BoardsInterventionKnowledgeLeadLouisianaLow incomeMeasuresMethodsMinority GroupsMultimediaObesityOutcomeParticipantPhasePopulationPositioning AttributePremature MortalityProviderQuestionnairesRADx Underserved PopulationsRandomizedReportingResearch DesignResearch Project GrantsResourcesSafetySamplingSchoolsSiteSocietiesSourceSouth AmericanStructureTestingTrainingTranslational ResearchTrustUnderserved PopulationUnited StatesUnited States National Institutes of HealthUrban CommunityUrsidae FamilyVaccinatedVaccinesWorkbasecommunity centercommunity engaged researchcommunity engagementcomorbidityeffectiveness evaluationgroup interventionhealth disparityhealth economicsimprovedintervention effectlow socioeconomic statusmembermortalityprimary outcomeprogramsrandomized trialresponseside effecttesting uptaketrial designurban underservedvaccine acceptancevaccine accessvaccine hesitancy
中文摘要
项目总结/摘要
在美国,COVID-19在低收入和医疗服务不足的人群中造成了不成比例的健康负担,
社会在路易斯安那州,一些最大的健康和经济后果在我们的黑人中很明显。
社区.此外,尽管SARS-CoV-2疫苗广泛可用,但约30%的
美国人口报告说,他们不会接种疫苗,黑人公民和社会地位较低的人,
经济状况更容易产生疫苗犹豫。因此,迫切需要解决疫苗
在COVID-19大流行和当前测试环境下的犹豫。路易斯安那
临床和转化科学(LA CaTS)中心提供必要的基础设施和关键的基础
支持我们地区的生物医学研究,并具有独特的优势,能够领导社区参与
研究项目,以确定解决方案,以减少疫苗犹豫和提高测试率,在我们最
服务不足的人群。宗教组织(教堂、清真寺、寺庙等)是可靠的
信息,特别是在黑人社区,并可能代表一个机会,传达准确,
向社区提供有关COVID-19疫苗接种和检测的公正健康信息。许多黑人
教会有完善的卫生部,为他们的成员整合信仰和健康,
他们服务的社区。我们将使用混合方法研究设计来确定
培训教会卫生部长,教育他们的会众关于安全和有效性的
COVID-19疫苗用于减少疫苗犹豫并提高服务不足人群的检测知识
黑人社区。我们将从五个教会随机抽取98名参与者,
接受他们的卫生部长关于接种疫苗和检测的好处的咨询,或者推迟接种疫苗。
干预对照组。干预对主要结局的影响,测量疫苗犹豫
通过结构化问卷调查,将在三周后进行研究。经过三周的控制期,
延迟干预对照组同时进行干预。然后,我们将进行焦点小组讨论,
参与者的子样本,以获得关于疫苗犹豫来源的更详细信息,
疫苗相关的决定。研究目标的实现将大大增加我们对
路易斯安那州黑人城市社区的疫苗犹豫。我们的研究结果将为开发
有针对性的干预措施,以增加美国各地大量未得到充分服务的人群的疫苗覆盖率
南
英文摘要
Project Summary/Abstract
In the US, COVID-19 unveiled a disproportionate health burden in low income and underserved segments of
society. In Louisiana, some of the greatest health and economic consequences are evident in our Black
communities. Furthermore, despite the widespread availability of SARS-CoV-2 vaccines, approximately 30% of
the US population reports that they will not get vaccinated, and Black citizens and those with lower socio-
economic status are more likely to have vaccine hesitancy. Thus, there is an urgent need to address vaccine
hesitancy within the context of the COVID-19 pandemic and the current testing environment. The Louisiana
Clinical and Translational Science (LA CaTS) Center provides the essential infrastructure and key foundational
support for biomedical research in our region and is uniquely positioned to lead a community-engaged
research project to determine solutions to decrease vaccine hesitancy and improve testing rates in our most
underserved populations. Faith-based organizations (churches, mosques, temples, etc.) are trusted sources of
information, especially among Black communities, and may represent an opportunity to convey accurate,
unbiased health information regarding COVID-19 vaccinations and testing to the community. Many Black
churches have well-developed health ministries that integrate faith and health for their members and the
communities they serve. We will use a mixed-methods study design to determine the effectiveness of
training church health ministers to educate their congregations about the safety and efficacy of
COVID-19 vaccines for decreasing vaccine hesitancy and improving testing knowledge in underserved
Black communities. We will randomize 98 participants from five churches to an intervention group that will
receive counseling from their health ministers on the benefits of getting vaccinated and tested, or to a delayed
intervention control group. The effects of the intervention on the primary outcome, vaccine hesitancy measured
by a structured questionnaire, will be studied after three weeks. Following the three-week control period, the
delayed intervention control group will also receive the intervention. We will then conduct focus groups among
a sub-sample of participants to obtain more granular information on sources of vaccine hesitancy and for their
vaccine-related decisions. The achievement of the study's goals will significantly increase our understanding of
vaccine hesitancy within Black urban communities in Louisiana. Our results will inform the development of
targeted interventions to increase vaccine coverage in the large, underserved populations across the American
South.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Louisiana Clinical and Translational Science Center
-
批准号:10415589
-
项目类别:
-
资助金额:$96.2万
-
财政年份:2021
-
负责人:JOHN P. KIRWAN
-
依托单位:
Louisiana Clinical and Translational Science Center
-
批准号:10258534
-
项目类别:
-
资助金额:$96.2万
-
财政年份:2020
-
负责人:JOHN P. KIRWAN
-
依托单位:
Role and Regulation of Skeletal Muscle Mitochondrial Dynamics in Type 2 Diabetes
-
批准号:9767119
-
项目类别:
-
资助金额:$65.87万
-
财政年份:2015
-
负责人:JOHN P. KIRWAN
-
依托单位:
Role of the skeletal muscle/pancreatic axis in type 2 diabetes
-
批准号:9014518
-
项目类别:
-
资助金额:$17.32万
-
财政年份:2015
-
负责人:JOHN P. KIRWAN
-
依托单位:
Role and Regulation of Skeletal Muscle Mitochondrial Dynamics in Type 2 Diabetes
-
批准号:9336293
-
项目类别:
-
资助金额:$69.84万
-
财政年份:2015
-
负责人:JOHN P. KIRWAN
-
依托单位:
Role of the skeletal muscle/pancreatic axis in type 2 diabetes
-
批准号:8815628
-
项目类别:
-
资助金额:$20.51万
-
财政年份:2015
-
负责人:JOHN P. KIRWAN
-
依托单位:
Louisiana Clinical and Translational Science Center - N3C supplement
-
批准号:10884657
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Health Disparities and SARS-COV-2 Evolution: A Focused Viral Genomics Study
-
批准号:10381371
-
项目类别:
-
资助金额:$73.76万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Louisiana Clinical and Translational Science Center
-
批准号:10513330
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Louisiana Clinical and Translational Science Center
-
批准号:10677678
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
LA CaTS Supplement NOT-GM-21-018 "Pregnancy Complications and Cardiometabolic Health in American Indian Women"
-
批准号:10395256
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Administrative Core
-
批准号:10678311
-
项目类别:
-
资助金额:$12.4万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Administrative Core
-
批准号:10201618
-
项目类别:
-
资助金额:$47.13万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Louisiana Clinical and Translational Science Center
-
批准号:10842136
-
项目类别:
-
资助金额:$77.57万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Louisiana Clinical and Translational Science Center Supplement - COVID Sequence Surveillance Network
-
批准号:10657250
-
项目类别:
-
资助金额:$12.4万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Louisiana Clinical and Translational Science Center
-
批准号:10201617
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
SARS-COV-2 Sequence Surveillance: Molecular Epidemiology, Clinical Correlations and Prospective Monitoring
-
批准号:10595375
-
项目类别:
-
资助金额:$72.67万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Louisiana Clinical and Translational Science Center
-
批准号:9520251
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Administrative Core
-
批准号:10513331
-
项目类别:
-
资助金额:$48.09万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
Louisiana Clinical and Translational Science Center - N3C supplement
-
批准号:10675402
-
项目类别:
-
资助金额:$20.79万
-
财政年份:2012
-
负责人:JOHN P. KIRWAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
微米和纳米塑料作用下2019-nCoV抗病毒药物利巴韦林对河蚬的毒性作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:郭晓宇
-
依托单位:
2019-nCoV感染导致人体淋巴细胞减低机制及其对机体免疫功能影响
-
批准号:82030002
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:曹彬
-
依托单位:
基于人口流动大数据的新型冠状病毒(2019-nCoV)输出感染风险及接触网络传播模型研究
-
批准号:--
-
项目类别:--
-
资助金额:135万元
-
批准年份:2020
-
负责人:吕欣
-
依托单位:
云南驯养野生动物中新型冠状病毒(2019-nCoV)溯源调查与验证
-
批准号:--
-
项目类别:--
-
资助金额:140万元
-
批准年份:2020
-
负责人:夏雪山
-
依托单位:
新型冠状病毒(2019-nCoV)反向遗传系统及啮齿类感染模型的建立与应用
-
批准号:--
-
项目类别:--
-
资助金额:150万元
-
批准年份:2020
-
负责人:黄耀伟
-
依托单位:
血必净预防2019-nCoV肺炎发生ARDS及机制研究
-
批准号:82041003
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:宋元林
-
依托单位:
新型冠状病毒2019-nCoV复制复合体关键蛋白的功能与潜在药物靶点研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:郭德银
-
依托单位:
2019-nCoV蝙蝠及人群代表性流行株致病能力的比较研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:周鹏
-
依托单位:
人新型冠状病毒2019-nCoV受体利用介导的种间传播和感染机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:140万元
-
批准年份:2020
-
负责人:葛行义
-
依托单位:
2019-nCoV“不典型症状”感染者的宿主因素及其作用机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:张文宏
-
依托单位: